| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| Roex, Inc. |
| 2801 Business Center Drive, Suite 185, Irvine, CA 92612 * (949) 476-8675 |
| Business Description | The company develops and markets its own line of dietary supplement products using scientifically based branded ingredients. |
|
Filing Information Not yet | |||
| To Trade As | ROEX (OTC) | Industry | Pharmaceutical (SIC 2833) |
| Type of Stock Offered | Common Shares | Filing Date | 12/8/99 |
| Domestic Shares Filed | 1,000,000 | Filing Range | $5.00 - $6.00 |
| Foreign Shares Filed | 0 | Offering Amount | $5,500,000 |
| Company Shares | 1,000,000 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | 5,788,584 |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| RH Investment Corporation | Lead Manager |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 9 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/97 | 12/31/98 | 9/30/98 | 9/30/99 | |||
| Revenues | - | - | - | 3.024 | 3.935 | 3.003 | 4.115 |
| Income from Oper. | - | - | - | - | - | - | - |
| Net Income | - | - | - | -0.512 | -0.463 | -0.437 | 0.417 |
| E.P.S | - | - | - | -0.110 | -0.100 | -0.090 | 0.080 |
| Revenue Growth (%) | - | - | - | 30.143 | 37.05 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | 10.14 | - |
| Cash Flow - Oper. | -0.11 | -0.04 | 0.23 | ||||
| Cash Flow - Inv. | -0.01 | -0.01 | -0.01 | ||||
| Cash Flow - Fin. | 0.03 | -0.05 | -0.12 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 9/30/99 | Financial Ratios | ||||
| Total Assets | 0.63 | Current Assets | 0.42 | Current Ratio | 0.58 |
| Total Liab. | 1.14 | Current Liab. | 0.73 | Debt Ratio | 181.46% |
| Total Equity | -0.51 | Working Cap. | -0.31 | Debt to Equity Ratio | - |
| Cash | 0.15 | Return on Assets | 66.37% | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to increase our inventory of products, add new radio markets, reduce our debt and for working capital and for general corporate purposes. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Barnett, William B. |
| Registrar/Transfer Agent | U. S. Stock Transfer Corporation |
| Auditor | Stonefield Josephson |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Rodney H. Burreson | 54.70 | |
| Bison Group | 13.20 | |
| Note: represents ownership of 5% or more prior to the offering. | ||